TIMP1/FAK/PI3K/AKT 신호 전달 경로를 통한 갑상선암 치료를 위한 호모하링토닌 재목적화

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1<p>MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma</p>2019 · 25 citations
2. 2Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms2005 · 41 citations
3. 3Targeting PI3K/Akt signal transduction for cancer therapy2021 · 1,825 citations
4. 4Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer2004 · 124 citations
5. 5Homoharringtonine deregulates <i>MYC</i> transcriptional expression by directly binding NF-κB repressing factor2019 · 112 citations